|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/11/20 HBM BioCapital II LP SC 13G/A 2:100K Allena Pharmaceuticals, Inc. Toppan Merrill/FA HBM Biocapital II Management Ltd. |
Document/Exhibit Description Pages Size
1: SC 13G/A Amendment to Statement of Acquisition of HTML 57K
Beneficial Ownership by a Passive Investor
2: EX-1 Underwriting Agreement HTML 12K
JOINT FILING AGREEMENT
The undersigned hereby agree that this Schedule 13G with respect to the common stock, par value $0.001 per share, of Allena Pharmaceuticals, Inc., a Delaware corporation, is, and any amendments hereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: February 11, 2020
|
|
HBM BIOCAPITAL II LP | |
|
|
|
|
|
|
By: |
/s/ Mathew Hague |
|
|
Name: |
|
|
|
Title: |
Authorized Signatory |
|
|
|
|
|
|
By: |
/s/ Gunarathnam Gunasekaran |
|
|
Name: |
Gunarathnam Gunasekaran |
|
|
Title: |
Authorized Signatory |
|
|
|
|
|
|
HBM BIOCAPITAL II MANAGEMENT LTD. | |
|
|
|
|
|
|
By: |
/s/ Matthew Hague |
|
|
Name: |
|
|
|
Title: |
Authorized Signatory |
|
|
|
|
|
|
By: |
/s/ Gunarathnam Gunasekaran |
|
|
Name: |
Gunarathnam Gunasekaran |
|
|
Title: |
Authorized Signatory |
SIGNATURE PAGE TO JOINT FILING AGREEMENT (ALLENA PHARMACEUTICALS, INC.)
| This ‘SC 13G/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/11/20 | None on these Dates | ||
| List all Filings | ||||